Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Virtual workshop

- PMLiVE

QiC Programme now online

The Quality in Care Programme – a new initiative to celebrate good healthcare practice in the UK – has launched a website and blog

DH health analysis provider to be sold

The UK's Department of Health is to sell its health information provider Dr Foster Intelligence, in which it holds a minority stake

NTAC campaign delivers on QIPP

An NHS campaign to encourage UK specialists to adopt latest medical technology has proven a success, engaging more than 20,000 doctors

Decline in NICE drug approvals

An analysis of appraisals from the UK's National Institute for Health and Clinical Excellence has found access to drugs grew more restrictive between 2007 and 2009

NICE recommends against azacitidine

The UK’s NICE has recommended against the use of azacitidine for certain haematological conditions in draft guidance

NICE’s drug powers to be divested

GP consortia will decide on drug funding, rather than UK's NHS drug watchdog

£600m UK Cancer Drugs Fund confirmed

The UK's Department of Health has confirmed a Cancer Drugs Fund of £600m to give cancer patients in England greater access to treatments

NICE issues final guidance on liraglutide

NICE publishes final guidance on the use of liraglutide (brand name Victoza) for people with type 2 diabetes in England, Wales and Northern Ireland

National Dementia Declaration launched

The UK's National Institute for Health and Clinical Excellence has joined forces with 44 other organisations to form Dementia Action Alliance

Comments on UK spending review

UK's ABPI and BIA comment on the government's commitment to healthcare and life sciences following the Comprehensive Spending Review

DH bodies to be axed

Thirty public bodies related to the UK Department of Health are to be axed or reconstituted as part of government efforts to reform public services

UK government halts generic drug plans

The UK's coalition government has said it has decided not to progress with plans to replace branded drugs with generic medicines in primary care

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links